Showing results (141-150 of 296) with videos related to
Sort By:
Pageof 30
Journal of the American Heart Association|March 3, 2025
Illuminating Cardiac Remodeling: Insights From [18F]-Fluorodeoxyglucose Positron Emission Tomography Imaging in Plakoglobin-Associated Arrhythmogenic CardiomyopathyTatjana Williams, Regina Groß, Anahi-Paula Arias-Loza, et al.Circulation. Arrhythmia and Electrophysiology|October 8, 2009
Feasibility of real-time MRI with a novel carbon catheter for interventional electrophysiologyPeter Nordbeck, Wolfgang R Bauer, Florian Fidler, et al.Journal of the American Society of Nephrology : JASN|November 3, 2018
Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry DiseaseMalte Lenders, Leon Paul Neußer, Michael Rudnicki, et al.Frontiers in Cardiovascular Medicine|March 29, 2021
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 StudyWolfgang Ries, Jan Torzewski, Franz Heigl, et al.Cardiovascular Research|June 14, 2005
The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive ratsTheo Pelzer, Virginija Jazbutyte, Kai Hu, et al.Magma (New York, N.Y.)|January 21, 2009
In vivo comparison of atherosclerotic plaque progression with vessel wall strain and blood flow velocity in apoE(-/-) mice with MR microscopy at 17.6 TVolker Herold, Jeremy Wellen, Christian H Ziener, et al.The International Journal of Cardiovascular Imaging|July 17, 2015
Impact of monitoring longitudinal systolic strain changes during serial echocardiography on outcome in patients with AL amyloidosisKai Hu, Dan Liu, Peter Nordbeck, et al.European Heart Journal|April 9, 2019
Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized controlled ICD-FORUM trialStefan M Schulz, Oliver Ritter, Richard Zniva, et al.Journal of Cancer Research and Clinical Oncology|February 19, 2022
Anti-CD20-atezolizumab-polatuzumab vedotin in relapsed/refractory follicular and diffuse large B-cell lymphomaMax S Topp, Herbert Eradat, Axel Florschütz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trialAndreas Engert, Andreas Josting, Heinz Haverkamp, et al.Pageof 30